Harrow Financial Ratios
NASDAQ: HROWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Harrow ratio analysis
Harrow earned a net margin of -1.9% in FY 2025, up from -8.8% a year earlier. Gross margin was 75.1% compared with a median of 69.6% over the prior 9 years. Return on equity reached -9.8%, meaning Harrow generated -0.10 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 4.64 versus 3.15 the year before, and the current ratio was 2.20. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Harrow financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | — | — | — | 715.00 | 8.84 | — | — |
| Price / sales | 6.74 | 6.49 | 2.81 | 4.58 | 3.19 | 3.63 | 3.54 | 2.86 | 1.27 | 1.60 |
| Price / book | 34.98 | 18.60 | 5.16 | 14.69 | 20.48 | 6.54 | 6.53 | 4.77 | 13.02 | 4.95 |
| Gross margin | 75.1% | 75.3% | 69.6% | 71.3% | 74.9% | 70.4% | 67.3% | 60.1% | 49.6% | 50.7% |
| Operating margin | 11.2% | 4.4% | 0.3% | 2.2% | 2.2% | 0.8% | -9.4% | -12.6% | -45.4% | -79.6% |
| Net margin | -1.9% | -8.8% | -18.7% | -15.9% | -24.8% | -6.9% | 0.3% | 35.3% | -44.8% | -95.7% |
| Free cash flow margin | 15.8% | -11.9% | 1.8% | -1.0% | 4.5% | -4.0% | -1.0% | -2.6% | -35.8% | -90.8% |
| Return on equity (ROE) | -9.8% | -25.1% | -34.5% | -51.0% | -159.6% | -12.3% | 0.6% | 59.1% | -458.3% | -296.8% |
| Return on assets (ROA) | -1.3% | -4.5% | -7.8% | -9.0% | -18.3% | -5.8% | 0.3% | 29.6% | -50.1% | -70.1% |
| Debt / equity | 4.64 | 3.15 | 2.63 | 3.78 | 6.35 | 0.46 | 0.44 | 0.51 | 5.36 | 1.23 |
| Current ratio | 2.20 | 2.08 | 2.83 | 6.35 | 6.24 | 3.79 | 2.93 | 2.76 | 1.53 | 1.49 |
| Revenue growth | 36.4% | 53.3% | 47.0% | 22.2% | 48.3% | -4.5% | 23.7% | 54.5% | 34.3% | 105.2% |
| EPS growth | — | — | — | — | — | -1,400.0% | -98.4% | — | — | — |